Palisade Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,734
Closed -$368K 379
2023
Q3
$368K Hold
1,734
0.01% 342
2023
Q2
$334K Hold
1,734
0.01% 342
2023
Q1
$351K Sell
1,734
-51
-3% -$8.18K 0.01% 361
2022
Q4
$229K Sell
1,785
-215
-11% -$27.7K 0.01% 386
2022
Q3
$274K Hold
2,000
0.01% 385
2022
Q2
$354K Hold
2,000
0.01% 390
2022
Q1
$288K Hold
2,000
0.01% 392
2021
Q4
$309K Hold
2,000
0.01% 400
2021
Q3
$340K Hold
2,000
0.01% 376
2021
Q2
$316K Hold
2,000
0.01% 376
2021
Q1
$278K Hold
2,000
0.01% 357
2020
Q4
$350K Buy
+2,000
New +$373K 0.01% 345
2020
Q3
Sell
-2,000
Closed -$340K 407
2020
Q2
$340K Hold
2,000
0.01% 350
2020
Q1
$231K Hold
2,000
0.01% 395
2019
Q4
$229K Buy
+2,000
New +$212K 0.01% 394

Other funds holding SGEN

Palisade Capital Management's SGEN Position: Q4 2023 in Review

Palisade Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,734 shares — an estimated $368K sold.

Palisade Capital Management first reported a position in SGEN in Q4 2019 and held it in 15 quarters. The position peaked at $368K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Palisade Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Palisade Capital Management sold 1,734 Seagen Inc. Common Stock shares in Q4 2023, an estimated $368K.
  • Palisade Capital Management first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 15 quarters.
  • Palisade Capital Management's Seagen Inc. Common Stock position peaked at $368K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Palisade Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.